Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Pende

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Molecular Aspects of Medicine|August 18, 2020
NK cells and ILCs in tumor immunotherapySimona Sivori, Daniela Pende, Linda Quatrini, et al.
Cancer Research|May 4, 2005
Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96Lorenzo Pilla, Paola Squarcina, Jorgelina Coppa, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2014
Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 bindingValentina Cetica, Yvonne Hackmann, Samantha Grieve, et al.
Frontiers in Immunology|August 27, 2019
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to TherapiesAlessandra Marrella, Alessandra Dondero, Maurizio Aiello, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 15, 2017
Prevention of systemic toxicity in hyperthermic isolated lung perfusion using radioisotopic leakage monitoringFrancesco Fiz, Giuseppe Villa, Enrico Ferrari, et al.
Frontiers in Immunology|October 5, 2020
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of CancerSimona Sivori, Mariella Della Chiesa, Simona Carlomagno, et al.
Plos One|December 10, 2009
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cellsPaolo Carrega, Gaetana Pezzino, Paola Queirolo, et al.
Experimental Hematology|July 8, 2009
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30Mirna Balsamo, Renato Zambello, Antonella Teramo, et al.
Cytometry. Part B, Clinical Cytometry|January 6, 2017
Markers and function of human NK cells in normal and pathological conditionsGenny Del Zotto, Emanuela Marcenaro, Paola Vacca, et al.
Cancers|July 25, 2019
CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15Heleen H Van Acker, Zoë P Van Acker, Maarten Versteven, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Molecular Aspects of Medicine|August 18, 2020
NK cells and ILCs in tumor immunotherapySimona Sivori, Daniela Pende, Linda Quatrini, et al.
Cancer Research|May 4, 2005
Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96Lorenzo Pilla, Paola Squarcina, Jorgelina Coppa, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2014
Patients with Griscelli syndrome and normal pigmentation identify RAB27A mutations that selectively disrupt MUNC13-4 bindingValentina Cetica, Yvonne Hackmann, Samantha Grieve, et al.
Frontiers in Immunology|August 27, 2019
Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to TherapiesAlessandra Marrella, Alessandra Dondero, Maurizio Aiello, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|July 15, 2017
Prevention of systemic toxicity in hyperthermic isolated lung perfusion using radioisotopic leakage monitoringFrancesco Fiz, Giuseppe Villa, Enrico Ferrari, et al.
Frontiers in Immunology|October 5, 2020
Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of CancerSimona Sivori, Mariella Della Chiesa, Simona Carlomagno, et al.
Plos One|December 10, 2009
Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cellsPaolo Carrega, Gaetana Pezzino, Paola Queirolo, et al.
Experimental Hematology|July 8, 2009
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NKp30Mirna Balsamo, Renato Zambello, Antonella Teramo, et al.
Cytometry. Part B, Clinical Cytometry|January 6, 2017
Markers and function of human NK cells in normal and pathological conditionsGenny Del Zotto, Emanuela Marcenaro, Paola Vacca, et al.
Cancers|July 25, 2019
CD56 Homodimerization and Participation in Anti-Tumor Immune Effector Cell Functioning: A Role for Interleukin-15Heleen H Van Acker, Zoë P Van Acker, Maarten Versteven, et al.
Pageof 11